Echtenacher B - Search Results

1

Functional role of melanoma inhibitory activity in regulating invasion and metastasis of malignant melanoma cells in vivo.

Bosserhoff AK, Echtenacher B, Hein R, Buettner R. Bosserhoff AK, et al. Among authors: echtenacher b. Melanoma Res. 2001 Aug;11(4):417-21. doi: 10.1097/00008390-200108000-00013. Melanoma Res. 2001. PMID: 11479431

2

BMP6-induced modulation of the tumor micro-milieu.

Stieglitz D, Lamm S, Braig S, Feuerer L, Kuphal S, Dietrich P, Arndt S, Echtenacher B, Hellerbrand C, Karrer S, Bosserhoff AK. Stieglitz D, et al. Among authors: echtenacher b. Oncogene. 2019 Jan;38(5):609-621. doi: 10.1038/s41388-018-0475-x. Epub 2018 Aug 31. Oncogene. 2019. PMID: 30171260

3

Hypoferraemia during the early inflammatory response is dependent on tumour necrosis factor activity in a murine model of protracted peritonitis.

Schubert TE, Bosserhoff AK, Peyssonaux C, Echtenacher B, Knutson M, Hofstädter F, Männel DN. Schubert TE, et al. Among authors: echtenacher b. Mol Med Rep. 2012 Oct;6(4):838-42. doi: 10.3892/mmr.2012.1004. Epub 2012 Jul 24. Mol Med Rep. 2012. PMID: 22842669

4

Lysis of tumor cells by natural killer cells in mice is impeded by platelets.

Nieswandt B, Hafner M, Echtenacher B, Männel DN. Nieswandt B, et al. Among authors: echtenacher b. Cancer Res. 1999 Mar 15;59(6):1295-300. Cancer Res. 1999. PMID: 10096562

5

Antimetastatic effect of CpG DNA mediated by type I IFN.

Hafner M, Zawatzky R, Hirtreiter C, Buurman WA, Echtenacher B, Hehlgans T, Männel DN. Hafner M, et al. Among authors: echtenacher b. Cancer Res. 2001 Jul 15;61(14):5523-8. Cancer Res. 2001. PMID: 11454702

6

Interleukin-12 activates NK cells for IFN-gamma-dependent and NKT cells for IFN-gamma-independent antimetastatic activity.

Hafner M, Falk W, Echtenacher B, Männel DN. Hafner M, et al. Among authors: echtenacher b. Eur Cytokine Netw. 1999 Dec;10(4):541-8. Eur Cytokine Netw. 1999. PMID: 10586121 Free article.

7

VEGF/Flk-1 interaction, a requirement for malignant ascites recurrence.

Stoelcker B, Echtenacher B, Weich HA, Sztajer H, Hicklin DJ, Männel DN. Stoelcker B, et al. Among authors: echtenacher b. J Interferon Cytokine Res. 2000 May;20(5):511-7. doi: 10.1089/10799900050023933. J Interferon Cytokine Res. 2000. PMID: 10841080

8

Critical protective role of mast cell-derived tumour necrosis factor in bacterial infection.

Männel DN, Hültner L, Echtenacher B. Männel DN, et al. Among authors: echtenacher b. Res Immunol. 1996 Oct-Dec;147(8-9):491-3. doi: 10.1016/s0923-2494(97)85212-1. Res Immunol. 1996. PMID: 9127878 Review. No abstract available.

9

Requirement of TNF and TNF receptor type 2 for LPS-induced protection from lethal septic peritonitis.

Echtenacher B, Männel DN. Echtenacher B, et al. J Endotoxin Res. 2002;8(5):365-9. doi: 10.1179/096805102125000696. J Endotoxin Res. 2002. PMID: 12537695

10

TNF-independent development of transient anemia of chronic disease in a mouse model of protracted septic peritonitis.

Schubert T, Echtenacher B, Hofstädter F, Männel DN. Schubert T, et al. Among authors: echtenacher b. Lab Invest. 2003 Dec;83(12):1743-50. doi: 10.1097/01.lab.0000101693.12149.2c. Lab Invest. 2003. PMID: 14691292 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

58 results

Search Page